Loading...
Bioventus Inc. reported a 4.0% increase in net sales, a 133.9% increase in net income, and completed the acquisition of Bioness. They also raised full year 2021 revenue guidance by $4 million.
Net Sales of $81.8 million, up 4.0% year-over-year.
Net Income of $24.5 million, up 133.9% year-over-year.
Adjusted EBITDA of $11.1 million, down 22.3% year-over-year.
Completed acquisition of Bioness on March 30, 2021.
The Company now expects net sales of $394 million to $406 million, up approximately 23% to 26% year-over-year.
Visualization of income flow from segment revenue to net income